Literature DB >> 29119320

Total or subtotal glossectomy with laryngeal preservation: a national study of 29 patients.

Harri Keski-Säntti1, Leif Bäck2, Patrik Lassus3, Petri Koivunen4, Ilpo Kinnunen5, Henry Blomster6, Antti A Mäkitie2, Katri Aro2.   

Abstract

Total glossectomy remains a controversial procedure as it often leads to notorious sequalae in swallowing and speaking functions. Disease entities indicating total glossectomy tend to have poor prognosis. We evaluated whether this type of surgery can be concidered justified based on our national series. We reviewed all total and subtotal glossectomies with laryngeal preservation performed in Finland between 2005 and 2014 in terms of overall survival (OS), disease-specific survival (DSS), locoregional control (LRC), and functional outcome as assessed by gastric tube or tracheostomy dependence and ability to produce intelligible speech. Of the 29 eligible patients, 15 had undergone total and 14 subtotal glossectomy with curative intent. In eight patients, total/subtotal glossectomy was performed as salvage procedure after the previous treatment. One-year estimates for OS, DSS, and LRC were 48, 59, and 66%, and corresponding 3-year estimates were 31, 46, and 46%, respectively. The gastrostomy and tracheostomy dependence rates at 1 year after operation were 77 and 15%, respectively. Fifty-nine percent of the patients were assessed to be able to communicate verbally. As in most other published studies, we found unsatisfactory survival figures after subtotal or total glossectomy and most patients remained dependent on gastrostomy tube. This surgery is, however, presumably the best and often only chance for cure in a selective patient population, and according to our opinion, it is indicated as a primary or salvage treatment provided that the reconstruction is planned optimally to guarantee a reasonable quality of life after surgery.

Entities:  

Keywords:  Glossectomy; Oral cancer; Quality of life; Survival; Tongue cancer; Tongue reconstruction

Mesh:

Year:  2017        PMID: 29119320     DOI: 10.1007/s00405-017-4789-z

Source DB:  PubMed          Journal:  Eur Arch Otorhinolaryngol        ISSN: 0937-4477            Impact factor:   2.503


  25 in total

1.  Analysis of the relations between the shape of the reconstructed tongue and postoperative functions after subtotal or total glossectomy.

Authors:  Yoshihiro Kimata; Minoru Sakuraba; Shigeyuki Hishinuma; Satoshi Ebihara; Ryuichi Hayashi; Takahiro Asakage; Takashi Nakatsuka; Kiyonori Harii
Journal:  Laryngoscope       Date:  2003-05       Impact factor: 3.325

2.  Modification of flap design for total mobile tongue reconstruction using a sensitive antero-lateral thigh flap.

Authors:  Nicolas Leymarie; Guillaume Karsenti; Benjamin Sarfati; Françoise Rimareix; Frederic Kolb
Journal:  J Plast Reconstr Aesthet Surg       Date:  2011-12-03       Impact factor: 2.740

3.  Indications, reconstructive techniques, and results for total glossectomy.

Authors:  Alejandro Mazarro; Alba de Pablo; Carolina Puiggròs; M Mercedes Velasco; Manel Saez; Jorge Pamias; Coro Bescós
Journal:  Head Neck       Date:  2016-02-02       Impact factor: 3.147

4.  Correlation of neotongue volume changes with functional outcomes after long-term follow-up of total glossectomy.

Authors:  In Sik Yun; Dong Won Lee; Won Jai Lee; Dae Hyun Lew; Eun Chang Choi; Dong Kyun Rah
Journal:  J Craniofac Surg       Date:  2010-01       Impact factor: 1.046

5.  Risk factors for gastric-tube dependence following tongue reconstruction.

Authors:  Shimpei Miyamoto; Minoru Sakuraba; Shogo Nagamatsu; Shuji Kayano; Kenichi Kamizono; Ryuichi Hayashi
Journal:  Ann Surg Oncol       Date:  2012-03-07       Impact factor: 5.344

6.  Chemoradiation for patients with advanced oral cavity cancer.

Authors:  Kerstin M Stenson; Rangesh Kunnavakkam; Ezra E W Cohen; Louis D Portugal; Elizabeth Blair; Daniel J Haraf; Joseph Salama; Everett E Vokes
Journal:  Laryngoscope       Date:  2010-01       Impact factor: 3.325

7.  The mushroom-shaped anterolateral thigh perforator flap for subtotal tongue reconstruction.

Authors:  Benedetto Longo; Marco Pagnoni; Germano Ferri; Roberto Morello; Fabio Santanelli
Journal:  Plast Reconstr Surg       Date:  2013-09       Impact factor: 4.730

8.  Total glossectomy without laryngectomy as first-line or salvage therapy.

Authors:  Béatrix Barry; Bertrand Baujat; Sébastien Albert; Emmanuel Nallet; Joël Depondt; Charles Guedon; Pierre Gehanno
Journal:  Laryngoscope       Date:  2003-02       Impact factor: 3.325

9.  The surgical dilemma of 'functional inoperability' in oral and oropharyngeal cancer: current consensus on operability with regard to functional results.

Authors:  A Kreeft; I B Tan; M W M van den Brekel; F J Hilgers; A J M Balm
Journal:  Clin Otolaryngol       Date:  2009-04       Impact factor: 2.597

Review 10.  Total glossectomy with laryngeal preservation and free flap reconstruction: objective functional outcomes and systematic review of the literature.

Authors:  Peter T Dziegielewski; Michael L Ho; Jana Rieger; Prabhjyot Singh; Morgan Langille; Jeffrey R Harris; Hadi Seikaly
Journal:  Laryngoscope       Date:  2012-09-05       Impact factor: 3.325

View more
  3 in total

1.  Oncological outcomes in patients undergoing major glossectomy for advanced carcinoma of the oral tongue.

Authors:  R Katna; B Bhosale; R Sharma; S Singh; A Deshpande; N Kalyani
Journal:  Ann R Coll Surg Engl       Date:  2020-05-21       Impact factor: 1.891

2.  Comparison of Treatment Outcomes Between Total and Near Total Glossectomy with Larynx Preservation and Flap Reconstruction: A Single Institution Experience with 23 Patients.

Authors:  Uygar Levent Demir; Mustafa Aslıer; Hakkı Caner İnan
Journal:  Turk Arch Otorhinolaryngol       Date:  2022-08-31

3.  Functional outcomes and survival of patients with oral and oropharyngeal cancer after total glossectomy.

Authors:  Isabela de Cássia Marins Quinsan; Gustavo Carvalho Costa; Antonio Vitor Martins Priante; Cesar Augusto Cardoso; Caio Lúcio Soubhia Nunes
Journal:  Braz J Otorhinolaryngol       Date:  2019-03-16
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.